NEUROMARK® Now with Expanded Access on UnitedHealthcare's Medicare Advantage Policy for Posterior Nasal Nerve Ablation

Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct. 22, 2025 /PRNewswire/ -- Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that...